Dishman Carbogen Amcis Ltd - Stock Valuation and Financial Performance

BSE: 540701 | NSE: DCAL | Pharmaceuticals & Drugs | Small Cap

Dishman Carbogen Amc Share Price

234.25 0.35 0.15%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Dishman Carbogen Amc

Overall Rating
Bole Toh

1. Quality

2. Valuation

Fair

3. Price Trend

Dishman Carbogen Amcis stock performance -

mw4me loader
P/E Ratio (CD):
0.00
Market Cap:
3,667.2 Cr.
52-wk low:
113.3
52-wk high:
283

Is Dishman Carbogen Amcis Ltd an attractive stock to invest in?

1. Is Dishman Carbogen Amcis Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Dishman Carbogen Amcis Ltd is a below average quality company.

2. Is Dishman Carbogen Amcis Ltd undervalued or overvalued?

The key valuation ratios of Dishman Carbogen Amcis Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Dishman Carbogen Amcis Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Dishman Carbogen Amcis Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

10 Year X-Ray of Dishman Carbogen Amc:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Dishman Carbogen Amcis Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'13Mar'14Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 0%0%0%3.4%3.3%4.2%3.3%-1.6%1%1.4%-
Value Creation
Index
NANANA-0.8-0.8-0.7-0.8-1.1-0.9-0.9-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0001,7141,6952,0592,0441,9122,1412,4132,580
Sales YoY Gr.-NANANA-1.1%21.5%-0.7%-6.4%12%12.7%-
Adj EPS 000010.213.810.9-8.91.92.7-9.8
YoY Gr.-NANANANA35.2%-21.2%-181.9%NA42.5%-
BVPS (₹) 0000316.4333.3364.3363.5353.9370.5364.3
Adj Net
Profit
000159165223171-14029.241.5-154
Cash Flow from Ops. 000303226282585513355220-
Debt/CF from Ops. 0003.14.83.71.82.348.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA7.3%5.7%12.7%
Adj EPS NA-23.7%-37.6%42.5%
BVPSNA3.2%0.6%4.7%
Share Price - 2.3% 28.9% 88%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'13Mar'14Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
0003.33.34.33.1-2.50.50.7-2.7
Op. Profit
Mgn %
00026.626.927.925.215.215.51610.7
Net Profit
Mgn %
0008.49.810.98.4-7.31.41.7-6
Debt to
Equity
000238.60.20.20.20.20.30.3-
Working Cap
Days
0000339308332346279254145
Cash Conv.
Cycle
00001391271421551411567

Recent Performance Summary

No data to display

Return on Equity is Poor

Sales growth has been subdued in last 3 years 5.69%

Sales growth is not so good in last 4 quarters at 9.96%

Latest Financials - Dishman Carbogen Amcis Ltd.

Standalone Consolidated
TTM EPS (₹) -3.5 -9.8
TTM Sales (₹ Cr.) 329 2,580
BVPS (₹.) 260.1 364.3
Reserves (₹ Cr.) 4,046 5,680
P/BV 0.90 0.64
PE 0.00 0.00
From the Market
52 Week Low / High (₹) 113.25 / 282.95
All Time Low / High (₹) 46.45 / 396.55
Market Cap (₹ Cr.) 3,667
Equity (₹ Cr.) 31.4
Face Value (₹) 2
Industry PE 47.8

Management X-Ray of Dishman Carbogen Amc:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Dishman Carbogen Amc

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales1,7141,6952,0592,0441,9122,1412,413
Operating Expenses 1,2601,2571,5071,5461,6381,8152,081
Manufacturing Costs148132171178160207259
Material Costs329337404459468447511
Employee Cost 5966257157628739811,035
Other Costs 187162217147137179275
Operating Profit 453438552498274326332
Operating Profit Margin (%) 26.5%25.8%26.8%24.3%14.3%15.2%13.8%
Other Income 26535444394928
Interest 49495762485786
Depreciation 214211240283308308281
Exceptional Items 0000-22-15-48
Profit Before Tax 216231309197-65-4-55
Tax 71769839100-22-25
Profit After Tax 145155210159-16518-30
PAT Margin (%) 8.5%9.1%10.2%7.8%-8.6%0.8%-1.2%
Adjusted EPS (₹)0.09.613.010.1-10.51.2-1.9
Dividend Payout Ratio (%)0%0%2%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 45,1075,3795,7155,6995,5495,810
Share Capital 0323231313131
Reserves 45,0755,3475,6845,6675,5185,778
Minority Interest0000000
Debt8459188839301,0461,2551,727
Long Term Debt4605253622415047621,047
Short Term Debt385393520688542493681
Trade Payables86186195284169193220
Others Liabilities 5,6409578641,2651,4411,6371,683
Total Liabilities 6,5747,1697,3218,1938,3568,6349,439

Fixed Assets

Gross Block6,1876,6216,8977,8918,1558,6339,458
Accumulated Depreciation1,3401,5601,8052,2182,4622,8653,275
Net Fixed Assets4,8475,0615,0925,6735,6935,7686,183
CWIP 1331511752344867801,043
Investments 40196167191172324249
Inventories427485549581516645804
Trade Receivables286444445577421473590
Cash Equivalents 876996161308172189
Others Assets755764796776760472381
Total Assets 6,5747,1697,3218,1938,3568,6349,439

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 303226282585513355220
PBT 216231309197-65-4-55
Adjustment 232235277330313325347
Changes in Working Capital -29-206-17413231690-38
Tax Paid -116-34-130-74-51-56-34
Cash Flow From Investing Activity -142-297-169-442-380-619-448
Capex -139-205-308-409-365-455-573
Net Investments 3-14868-2821-171104
Others -65671-6-36821
Cash Flow From Financing Activity -13778-102-98-11130250
Net Proceeds from Shares -1000000
Net Proceeds from Borrowing -98118-172-154169282167
Interest Paid -52-49-57-61-53-60-73
Dividend Paid -1900-3000
Others 338127121-127-92156
Net Cash Flow 2371146122-13322
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)3654.026.054.012.86-2.890.32-0.52
ROCE (%)4.64.675.793.93-0.260.760.43
Asset Turnover Ratio0.260.250.280.260.230.250.27
PAT to CFO Conversion(x)2.091.461.343.68N/A19.72N/A
Working Capital Days
Receivable Days61797991957680
Inventory Days91989210110599110
Payable Days95147172190177148147

Dishman Carbogen Amcis Ltd Stock News

Dishman Carbogen Amcis Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Dishman Carbogen Amc on 28-Mar-2024 16:01 is ₹234.2.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Dishman Carbogen Amc stood at ₹3,667.2.
The latest P/E ratio of Dishman Carbogen Amc as of 28-Mar-2024 16:01 is 0.00.
The latest P/B ratio of Dishman Carbogen Amc as of 28-Mar-2024 16:01 is 0.90.
The 52-week high of Dishman Carbogen Amc is ₹282.9 and the 52-week low is ₹113.2.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Dishman Carbogen Amc is ₹329.2 ( Cr.) .

About Dishman Carbogen Amcis Ltd

Incorporated in 1983, Dishman Carbogen Amcis Limited (DCAL) started out as a manufacturer of quaternary ammonium and phosphate compounds. Having ventured into the CRAMS space in India, the company soon became one of the fastest growing companies. Today, the company is a leading global outsourcing partner for the pharmaceutical industry, offering a portfolio of development, scale-up, and manufacturing services.

The company aids drug innovators for development and process optimization for novel drug molecules in various stages of the development process. Once the innovative molecules are approved, the company further explore the possibility of large scale commercial supply tie-ups. The company is generating a healthy pipeline of contract manufacturing opportunities commensurate to the growing revenue base of manufacturing. Its robust business model is capable of sustaining growth, with CRAMS being the focal point of all its strategic efforts.

Business area of the company

The company is a fully integrated CRAMS player working with global pharmaceutical innovators. It has a global presence with development and manufacturing facilities across Europe, India, and China. It provides end-to-end, integrated, high-value, niche CRAMS offering, right from process research & development to late-stage clinical and commercial manufacturing facilities along with the supply of Active Pharmaceutical Ingredients (API) to innovator pharmaceutical companies.

Products and services

  • CRAMS
  • Vitamin D & Analogues
  • Disinfectants
  • Highly Potent API Supply
  • Niche Generic API
  • Speciality Chemicals

History and Milestones

  • 1983: Incorporation of Dishman Pharmaceutical and Chemicals Limited.
  • 1989: Commencing production of Phase Transfer Catalysts at Naroda facility.
  • 1995: Entered into a JV with Schutz & Co. for manufacturing Chlorhexidine and Derivatives for European market.
  • 1996: Commencement of Bavla facility for Bulk Intermediates.
  • 2001: First commercial contract manufacturing agreement signed with a major western pharmaceutical company.
  • 2004: Came out with an IPO on Indian stock exchanges.
  • 2005: Acquisition of Synprotec - DCR (now known as CARBOGEN AMCIS Ltd, UK).
  • 2006: Acquisition of CARBOGEN AMCIS - a Swiss based CRAMS player.
  • 2007: Acquisition of Solvay Pharmaceuticals’ Vitamins and Chemicals business (now known as CARBOGEN AMCIS BV).
  • 2010: Commenced Dishman Shanghai manufacturing facility.
  • 2012: Acquisition of Riom (France) - CARBOGEN AMCIS SAS.
  • 2014: Acquisition of Vionnaz (CH) site - CARBOGEN AMCIS.
  • 2017: Change of name of the parent to Dishman Carbogen Amcis Limited, reinforcing the synergies between Dishman and Carbogen Amcis brands.
  • 2020: Global Reorganization of Roles and Responsibilities of the Management Team.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.